Intel Capital and Khosla Ventures Lead $27M Investment in SiPhox® Health to Transform Health Testing
The Series A round was led by Intel Capital with participation from Khosla Ventures, Kortex Ventures, Alumni Ventures, Metaplanet, Shorewind Capital, LongeVC, Overlap Holdings and Duke Capital Partners.
- The Series A round was led by Intel Capital with participation from Khosla Ventures, Kortex Ventures, Alumni Ventures, Metaplanet, Shorewind Capital, LongeVC, Overlap Holdings and Duke Capital Partners.
- Intel Capital managing director Srini Ananth will also join SiPhox Health’s board of directors to further accelerate the company’s growth.
- View the full release here: https://www.businesswire.com/news/home/20230719159332/en/
SiPhox Health co-founders standing in the SiPhox Health biochip pilot line and lab space. - In the meantime, SiPhox Health has launched a mail-in blood collection kit that measures 17 biomarkers for inflammation, metabolic, hormonal and cardiovascular health.